ASAP Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
Adds Medicare coverage for Alzheimer's disease and related dementias early detection screening tests and defines the eligible tests.
Who Benefits and How
Medicare beneficiaries could gain earlier access to covered Alzheimer's and dementia screening tests, including blood-based and comparable detection tools.
Who Bears the Burden and How
Federal health payers would face additional coverage costs and administrative work to implement the new screening benefit.
Key Provisions
- Adds Alzheimer's disease and related dementias early detection screening tests to Medicare-covered services.
- Defines the covered screening tests and allows the Secretary to recognize comparable tests.
- Updates payment provisions to include the new test category.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Adds Medicare coverage for Alzheimer's disease and related dementias early detection screening tests and defines the eligible tests.
Key Policy Areas
Healthcare, Social Welfare, Government Operations
Primary Purpose
Adds Medicare coverage for Alzheimer's disease and related dementias early detection screening tests and defines the eligible tests.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Medicare beneficiaries eligible for Alzheimer's and dementia early detection screening
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Federal Medicare payers and administrators
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMs. Collins (for herself, Ms. Cortez Masto, Mrs. Capito, and …
Read twice and referred to the Committee on Finance. (Sponsor …
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Providers furnishing covered Alzheimer's and dementia screening tests
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology